Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis

Status:
Completed

Trial end date:
2016-12-01

Target enrollment:

Participant gender:

Phase 2

Bausch Health Americas, Inc.
Valeant Pharmaceuticals International, Inc.

Tazarotene